Evidence map›Paper›PMID 37031316›Full record

ArticleCommunications biology2023

The role of RNF149 in the pre-emptive quality control substrate ubiquitination.

Aster Legesse, Nathali Kaushansky, Ilana Braunstein, Haddas Saad, Gerardo Lederkremer, Ami Navon, Ariel Stanhill

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Aster Legesse *Department of Natural and Life Sciences, Open University of Israel, Ra'anana, 43710, Israel.
Nathali Kaushansky *Department of Molecular Cell Biology, Weizmann institute of Science, Rehovot, 7610001, Israel.
Ilana BraunsteinDepartment of Biochemistry, Technion School of Medicine, Haifa, 31096, Israel.
Haddas SaadThe Shmunis School of Biomedicine and Cancer Research, George Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 69978, Israel.
Gerardo LederkremerThe Shmunis School of Biomedicine and Cancer Research, George Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 69978, Israel.ORCID 0000-0002-9857-7152
Ami NavonDepartment of Immunology and Regenerative Biology, Weizmann institute of Science, Rehovot, 7610001, Israel.
Ariel StanhillDepartment of Natural and Life Sciences, Open University of Israel, Ra'anana, 43710, Israel. stanhill@openu.ac.il.ORCID 0000-0002-0318-2212
Open University of Israel · ILTel Aviv University · ILWeizmann Institute of Science · ILTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein quality control is a process in which a protein's folding status is constantly monitored. Mislocalized proteins (MLP), are processed by the various quality control pathways, as they are often misfolded due to inappropriate cellular surroundings. Polypeptides that fail to translocate into the ER due to an inefficient signal peptide, mutations or ER stress are recognized by the pre-emptive ER associated quality control (pEQC) pathway and degraded by the 26 S proteasome. In this report we reveal the role of RNF149, a membrane bound E3 ligase in the ubiquitination of known pEQC substrates. We demonstrate its selective binding only to non-translocated proteins and its association with known pEQC components. Impairment in RNF149 function increases translocation flux into the ER and manifests in a myeloproliferative neoplasm (MPN) phenotype, a pathological condition associated with pEQC impairment. Finally, the dynamic localization of RNF149 may provide a molecular switch to regulate pEQC during ER stress.

Indexed as

Ubiquitin-Protein LigasesUbiquitinationUbiquitin-Protein Ligases

Identifiers

PMID37031316
PMCPMC10082771
OpenAlexW4362721928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.